1472Tip Organ Preservation with Durvalumab-Based Immunotherapy in Combination with Chemoradiation As Definitive Therapy for Early Stage, Ct1 and Ct2n0, Esophageal Adenocarcinoma: A Prospective, Multicenter Study of the FLOT-AIO Gastric Cancer Group – the IKF-057/ PRESTO Trial

N. Homann,T.O. Goetze, D. Janke, S. Kubicka, C. Müller,D. Pink, C. Dietrich,S. Ertl, S. Glag,T. Habibzada, S. Neumann, A. West, U. Tenekeci, C. Kopp,C. Pauligk,S-E. Al-Batran

Annals of Oncology（2024）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined